Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: antibacterials - Arrow Therapeutics

Drug Profile

Research programme: antibacterials - Arrow Therapeutics

Alternative Names: A 11259; A 158; A 161; A 20194; A 762; A 764; A-00000762; A-00026158; A-00026161; Antibacterials research programme - Arrow Therapeutics; Dehydroquinate synthase inhibitors research programme - Arrow Therapeutics; DHQS inhibitors - Arrow Therapeutics; Shikimate kinase inhibitors - Arrow Therapeutics; Type I dehydroquinase inhibitors - Arrow Therapeutics

Latest Information Update: 03 May 2004

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Arrow Therapeutics
  • Class
  • Mechanism of Action Dehydroquinate synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Gram-positive infections

Most Recent Events

  • 03 May 2004 Discontinued - Preclinical for Gram-positive infections in United Kingdom (unspecified route)
  • 26 Sep 2003 Data presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2003) have been added to the Bacterial Infections antimicrobial activity section
  • 13 Jan 2002 Preclinical development for Gram-positive infections in United Kingdom (Unknown route)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top